Flagship Ventures creates and finances companies in therapeutics, medical technologies and sustainability.

Click image for live video.


05.14.2012	BG Medicine, Inc. Announces Availability of Galectin-3 Diagnostic Testing Through Mayo Medical Laboratories
05.14.2012	BG Medicine Announces Publication of First Study on Use of Galectin-3 inSelection of Drug Therapy in Heart Failure
05.08.2012	Eleven Biotherapeutics Secures $20 Million and Expands Series A Financing
05.06.2012	US Scientists Who Mean Business
05.01.2012	Vaccine Could Stop Nicotine from Reaching the Brain
04.30.2012	Dr. Noubar Afeyan, Flagship's Managing Partner and CEO, speaking on Investor Panel at BIO World Congress on Industrial Biotechnology & Bioprocessing